title: QVA149 versus glycopyrronium for COPD - authors' reply.
authors.affiliation: Centre for Respiratory Medicine, University College London, Royal Free Campus, London NW3 2PF, UK. Electronic address: w.wedzicha@ucl.ac.uk.
authors.forename: Jadwiga A
authors.initials: JA
authors.lastname: Wedzicha
authors.affiliation: Respiratory Division, University Hospital, University of Leuven, Leuven, Belgium.
authors.forename: Marc
authors.initials: M
authors.lastname: Decramer
authors.affiliation: Paracelsus Medical University Nuremberg, Nuremberg, Germany; Klinikum Nuernberg, Department of Respiratory Medicine, Allergology, Sleep Medicine, Nuernberg, Germany.
authors.forename: Joachim H
authors.initials: JH
authors.lastname: Ficker
authors.affiliation: University of Minnesota, Minneapolis VA Medical Center, Minneapolis, MN, USA.
authors.forename: Dennis E
authors.initials: DE
authors.lastname: Niewoehner
authors.affiliation: Umea University, Department of Public Health and Clinical Medicine, Umea, Sweden.
authors.forename: Thomas
authors.initials: T
authors.lastname: Sandström
authors.affiliation: Novartis Pharmaceuticals, East Hanover, NJ, USA.
authors.forename: Angel Fowler
authors.initials: AF
authors.lastname: Taylor
authors.affiliation: Novartis Pharmaceuticals, East Hanover, NJ, USA.
authors.forename: Peter
authors.initials: P
authors.lastname: D'Andrea
authors.affiliation: Novartis Pharmaceuticals, East Hanover, NJ, USA.
authors.forename: Christie
authors.initials: C
authors.lastname: Arrasate
authors.affiliation: Novartis Pharmaceuticals, East Hanover, NJ, USA.
authors.forename: Hungta
authors.initials: H
authors.lastname: Chen
authors.affiliation: Novartis Pharmaceuticals, East Hanover, NJ, USA.
authors.forename: Donald
authors.initials: D
authors.lastname: Banerji
mesh_terms: D005260:Female; D006024:Glycopyrrolate / Q000031:analogs & derivatives*; D006801:Humans; D007189:Indans; D008297:Male; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D015363:Quinolones; D012137:Respiratory System / Q000187:drug effects*; D012602:Scopolamine Derivatives
chemical_list: D007189:Indans; D015363:Quinolones; D012602:Scopolamine Derivatives; D006024:Glycopyrrolate